Legacy Capital Group California, Inc. Abbott Laboratories Transaction History
Legacy Capital Group California, Inc.
- $301 Billion
- Q3 2024
A detailed history of Legacy Capital Group California, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Legacy Capital Group California, Inc. holds 7,203 shares of ABT stock, worth $834,827. This represents 0.27% of its overall portfolio holdings.
Number of Shares
7,203
Previous 7,210
0.1%
Holding current value
$834,827
Previous $749 Million
9.61%
% of portfolio
0.27%
Previous 0.27%
Shares
7 transactions
Others Institutions Holding ABT
# of Institutions
3,187Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.5 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.89 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.62 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.18 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $203B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...